deutsch deutschenglish english

AID LymeSpot EliSpot Assay – Detection of Interferon-y expression of borrelia-specific effector T cells

Measuring borrelia specific effector T cells


Diagnostic work-up of ambiguous serology

Borreliosis diagnostics is often based on the clinical appearance together with anamnesis and the evidence of specific antibodies.

Fundamentally, a positive Borrelia antibody test is separately no indicator for a therapy or reflects the clinical manifestations. In this case, detection of Borrelia-specific effector T cells can provide further diagnostic assistance.

The AID LymeSpot EliSpot Assay detects and measures the Interferon-y expression of Borrelia-specific effector T cells.


  • Alternative method to ELISA / WB with unclear diagnosis
  • For unclear chronic or neurological symptoms
  • Higher sensitivity and specificity
  • Therapy monitoring / prognosis possible
    also for seronegative “chronic borreliosis”
  • Functional control included in the kit
  • ELSP 5510